- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Outreach
- Careers
- About
- For Pain Patients and Professionals
Papers: 11 Feb 2023 - 17 Feb 2023
RESEARCH TYPE:
Review
Pharmacology/Drug Development
PAIN TYPE:
Migraine/Headache
2023 Mar
Cephalalgia
43
3
Direct comparisons of the tolerability and safety of migraine preventive treatments targeting the calcitonin gene-related peptide pathway are lacking. This study aimed to compare the safety and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies and gepants in migraine prevention.